日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment

对全人源抗PCSK9 IgG2单克隆抗体Evolocumab(AMG 145)在肝功能受损患者中的疗效评价

Gibbs, John P; Slatter, J Greg; Egbuna, Ogo; Geller, Michelle; Hamilton, Lisa; Dias, Clapton S; Xu, Ren Y; Johnson, Jessica; Wasserman, Scott M; Emery, Maurice G